Usefulness of Diffusion-weighted Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer

Academic Radiology

Volumn 19, Issue 10, 2012, Pages 1215-1224

  Wu, Lian Ming ^a   Xu, Jian Rong ^a   Gu, Hai Yan ^a   Hua, Jia ^a   Chen, Jie ^a   Zhang, Wei ^a   Zhu, Jiong ^a   Ye, Yong Quan ^b   Hu, Jiani ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Diagnosis; Diffusion weighted magnetic resonance imaging; Meta analysis; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREVALENCE; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

EID: 84865756277     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2012.05.016     Document Type: Article

References (43)

1. Bangma C.H., Kranse R., Blijenberg B.G., et al. The value of screening tests in the detection of prostate cancer. II. Retrospective analysis of free/total prostate-specific analysis ratio, agespecific reference ranges, and PSA density. Urology 1995, 46:779-784.
2. Pepe P., Panella P., D'Arrigo L., et al. Should men with serum prostatespecific antigen ≤4 ng/mL and normal digital rectal examination undergo a prostate biopsy? A literature review. Oncology 2006, 70:81-89.
3. Purohit R.S., Shinohara K., Meng M.V., et al. Imaging clinically localized prostate cancer. Urol Clin North Am 2003, 30:279-293.
4. Levine M.A., Ittman M., Melamed J., et al. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 1998, 159:471-475.
5. Djavan B., Waldert M., Zlotta A., et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol 2001, 166:856-860.
6. Sanchez-Chapado M., Angulo J.C., Ibarburen C., et al. Comparison of digital rectal examination, transrectal ultrasonography, and multicoil magnetic resonance imaging for preoperative evaluation of prostate cancer. Eur Urol 1997, 32:140-149.
7. Charles-Edwards E.M., deSouza N.M. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 2006, 6:135-143.
8. Haider M.A., van der Kwast T.H., Tanguay J., et al. Combined T2-weighted and diffusion weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 2007, 189:323-328.
9. Sato C., Naganawa S., Nakamura T., et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005, 21:258-262.
10. Shimofusa R., Fujimoto H., Akamata H., et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 2005, 29:149-153.
11. Mazaheri Y., Hricak H., Fine S.W., et al. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 2009, 252:449-457.
12. Miao H., Fukatsu H., Ishigaki T. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. Eur J Radiol 2007, 61:297-302.
13. Whiting P., Rutjes A.W., Reitsma J.B., et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25.
14. Rutter C.M., Gatsonis C.A. A hierarchical regression approach to metaanalysis of diagnostic test accuracy evaluations. Stat Med 2010, 20:2865-2884.
15. Zwinderman A.H., Bossuyt P.M. We should not pool diagnostic likelihood ratios in systematic reviews. Stat Med 2008, 27:687-697.
16. Yamamura J., Salomon G., Buchert R., et al. Magnetic resonance imaging of prostate cancer: diffusion-weighted imaging in comparison with sextant biopsy. J Comput Assist Tomogr 2011, 35:223-228.
17. Vilanova J.C., Barceló-Vidal C., Comet J., et al. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer. AJR Am J Roentgenol 2011, 196:W715-W722.
18. Nagayama M., Watanabe Y., Terai A., et al. Determination of the cutoff level of apparent diffusion coefficient values for detection of prostate cancer. Jpn J Radiol 2011, 29:488-494.
19. Iwazawa J., Mitani T., Sassa S., et al. Prostate cancer detection with MRI: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging?. Diagn Interv Radiol 2011, 17:243-248.
20. Yaĝci A.B., Ozari N., Aybek Z., et al. The value of diffusion-weighted MRI for prostate cancer detection and localization. Diagn Interv Radiol 2011, 17:130-134.
21. Rosenkrantz A.B., Kopec M., Kong X., et al. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. J Magn Reson Imaging 2010, 31:1387-1394.
22. Portalez D., Rollin G., Leandri P., et al. Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies. Eur Radiol 2010, 20:2781-2790.
23. Kim C.K., Park B.K., Kim B. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. AJR Am J Roentgenol 2010, 194:W33-W37.
24. Tamada T., Sone T., Jo Y., et al. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 2008, 248:531-539.
25. Chen M., Dang H.D., Wang J.Y., et al. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Acta Radiol 2008, 49:602-610.
26. Reinsberg S.A., Payne G.S., Riches S.F., et al. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol 2007, 188:91-98.
27. Kim C.K., Park B.K., Han J.J., et al. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results. J Comput Assist Tomogr 2007, 31:449-454. [published erratum appears in J Comput Assist Tomogr 2007; 31:656].
28. deSouza N.M., Reinsberg S.A., Scurr E.D., et al. Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules. Br J Radiol 2007, 80:90-95.
29. Kozlowski P., Chang S.D., Jones E.C., et al. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis-correlation with biopsy and histopathology. J Magn Reson Imaging 2006, 24:108-113.
30. Gibbs P., Pickles M.D., Turnbull L.W. Diffusion imaging of the prostate at 3.0 Tesla. Invest Radiol 2006, 41:185-188.
31. Horner MJ, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review 1975-2006. Available at: . Accessed August 17, 2009. http://seer.cancer.gov/csr/1975_2006/index.html.
32. Mullerad M., Hricak H., Kuroiwa K., et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 2005, 174:2158-2163.
33. Metens T., Miranda D., Absil J., et al. What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T?. Eur Radiol 2012, 22:703-709.
34. Qayyum A. Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications. Radiographics 2009, 29:1797-1810.
35. Kitajima K., Kaji Y., Kuroda K., et al. High b-value diffusion-weighted imaging in normal and malignant PZ tissue of the prostate: effect of signal-to-noise ratio. Magn Reson Med Sci 2008, 7:93-99.
36. Fütterer J.J., Engelbrecht M.R., Jager G.J., et al. Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectalcoil MR imaging. Eur Radiol 2007, 17:1055-1065.
37. Padhani A.R., Liu G., Koh D.M., et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009, 11:102-125.
38. Umbehr M., Bachmann L.M., Held U., et al. Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol 2009, 55:575-590.
39. Langer D.L., van der Kwast T.H., Evans A.J., et al. Prostate cancer detection with multiparametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 2009, 30:327-334.
40. Tanimoto A., Nakashima J., Kohno H., et al. Prostate cancer screening: the clinical value of diffusion weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 2007, 25:146-152.
41. Turkbey B., Pinto P.A., Mani H., et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection-histopathologic correlation. Radiology 2010, 255:89-99.
42. Kitajima K., Kaji Y., Fukabori Y., et al. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging 2010, 31:625-631.
43. Pham B., Platt R., McAuley L., et al. Is there a " best" way to detect and minimize publication bias? An empirical evaluation. Eval Health Prof 2001, 24:109-125.